Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Biliary Tract Diseases

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 37 articles: HTML format

Single Articles

July 2025
1. KIRCHGESNER J, Augustin J, Bazin T, Freiha P, et al
   A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
   Clin Res Hepatol Gastroenterol. 2025;49:102615.
   PubMed     Abstract available
   
   
   June 2025
2. GOYAL RM, Bansal B, Ayyad M, Singh A, et al
   Clinical outcomes in patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome in the United States.
   Clin Res Hepatol Gastroenterol. 2025;49:102598.
   PubMed     Abstract available
   
   
   
3. SANAVIO M, Camus M, Nammour JP, Godmer A, et al
   Clinical use of per ERCP bile aspiration in patients with cholangitis: The aspibile study.
   Clin Res Hepatol Gastroenterol. 2025;49:102599.
   PubMed     Abstract available
   
   
   April 2025
4. JAAN A, Zubair A, Farooq U, Nadeem H, et al
   Impact of frailty on outcomes and biliary drainage strategies in acute cholangitis: A retrospective cohort analysis.
   Clin Res Hepatol Gastroenterol. 2025;49:102568.
   PubMed     Abstract available
   
   
   January 2025
5. CORREIA FP, Coelho H, Francisco M, Alexandrino G, et al
   Predictive factors of spontaneous common bile duct clearance and unnecessary ERCP in patients with choledocholithiasis.
   Clin Res Hepatol Gastroenterol. 2025;49:102515.
   PubMed     Abstract available
   
   
   
6. SASAKI M, Sato Y, Nakanuma Y
   A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis.
   Clin Res Hepatol Gastroenterol. 2025;49:102512.
   PubMed     Abstract available
   
   
   October 2024
7. CANCADO GGL, Fucuta PDS, Gomes NMF, Couto CA, et al
   Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis.
   Clin Res Hepatol Gastroenterol. 2024;48:102453.
   PubMed     Abstract available
   
   
   
8. ZHAO B, Xue J, Zhang H
   Causal effects of smoking, alcohol consumption, and coffee intake on hepatobiliary and pancreatic diseases: A Mendelian randomization study.
   Clin Res Hepatol Gastroenterol. 2024;48:102450.
   PubMed     Abstract available
   
   
   
9. WANG M, Liu X, Qiao C, Chen R, et al
   Association of congenital hepatic fibrosis and Caroli's syndrome: Two illustrative cases.
   Clin Res Hepatol Gastroenterol. 2024;48:102443.
   PubMed    
   
   
   
10. GU S, Hu S, Wang S, Shi C, et al
    Altered biliary microbial and metabolic profile reveals the crosstalk between NAFLD and cholelithiasis.
    Clin Res Hepatol Gastroenterol. 2024;48:102431.
    PubMed     Abstract available
    
    
    
11. SHEN P, Shi Y, Xu P, Rao L, et al
    The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2024;48:102430.
    PubMed     Abstract available
    
    
    August 2024
12. LIN YL, Yao T, Wang YW, Yu JS, et al
    Association between primary biliary cholangitis with diabetes and cardiovascular diseases: A bidirectional multivariable Mendelian randomization study.
    Clin Res Hepatol Gastroenterol. 2024;48:102419.
    PubMed     Abstract available
    
    
    
13. TAO M, Wang X, Han J, Cao L, et al
    A new classification and laparoscopic treatment of extrahepatic choledochal cyst.
    Clin Res Hepatol Gastroenterol. 2024;48:102413.
    PubMed     Abstract available
    
    
    
14. SALIN G, Ouidir N, Hoyeau N, Leenhardt R, et al
    A uncommon lesion of the ampulla of Vater.
    Clin Res Hepatol Gastroenterol. 2024;48:102406.
    PubMed    
    
    
    
15. LI C, Dong Y, Zhang Y, Wu C, et al
    Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion.
    Clin Res Hepatol Gastroenterol. 2024;48:102398.
    PubMed     Abstract available
    
    
    
16. HU J, Mi Y, Wang L, Jiang F, et al
    Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102394.
    PubMed     Abstract available
    
    
    June 2024
17. ZHAO G, Shi R, Ma M, Lin H, et al
    Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study.
    Clin Res Hepatol Gastroenterol. 2024;48:102363.
    PubMed     Abstract available
    
    
    
18. TANAKA A, Corpechot C
    PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old.
    Clin Res Hepatol Gastroenterol. 2024;48:102358.
    PubMed     Abstract available
    
    
    May 2024
19. MARTINELLI G, Stanca S, Bosco F, Zini L, et al
    Massive lymphatic embolism in gallbladder signet ring cell carcinoma: An autopsy finding.
    Clin Res Hepatol Gastroenterol. 2024;48:102330.
    PubMed    
    
    
    
20. SALIN G, Corpechot C, Ouazana S, Dong C, et al
    Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study.
    Clin Res Hepatol Gastroenterol. 2024;48:102324.
    PubMed     Abstract available
    
    
    
21. LIANG Y, Li J, Zhang Z, Jiang T, et al
    Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk.
    Clin Res Hepatol Gastroenterol. 2024;48:102321.
    PubMed     Abstract available
    
    
    April 2024
22. YUE X, Cao S, Chen Y
    Acantholytic squamous cell carcinoma of the gallbladder: Report of a rare case with diagnostic challenges.
    Clin Res Hepatol Gastroenterol. 2024;48:102316.
    PubMed    
    
    
    January 2024
23. SEXTON F, Shanahan W, Ryan JD
    Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102255.
    PubMed    
    
    
    
24. NAYAGAM JS, Ahmed W, Farrant M, Jefferies J, et al
    Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: A single centre prospective study.
    Clin Res Hepatol Gastroenterol. 2024;48:102251.
    PubMed     Abstract available
    
    
    December 2023
25. ZHENG L, Zhou N, Yang X, Wei Y, et al
    Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Clin Res Hepatol Gastroenterol. 2023;47:102244.
    PubMed     Abstract available
    
    
    
26. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available
    
    
    November 2023
27. PASCALE A, Rosmorduc O, Duclos-Vallee JC
    New epidemiologic trends in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2023;47:102223.
    PubMed     Abstract available
    
    
    
28. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed     Abstract available
    
    
    October 2023
29. FILANOVSKY K, Temper N, Stanevsky A, Shvidel L, et al
    Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone.
    Clin Res Hepatol Gastroenterol. 2023;47:102198.
    PubMed    
    
    
    
30. DI GIORGIO A, Sciveres M, Fuoti M, Sonzogni A, et al
    Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency.
    Clin Res Hepatol Gastroenterol. 2023;47:102185.
    PubMed     Abstract available
    
    
    
31. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed     Abstract available
    
    
    August 2023
32. VO QUANG E, Ithier G, Jager M, Plessier A, et al
    Cholangiopathy in sickle cell disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102166.
    PubMed    
    
    
    May 2023
33. WISCHLEN E, Laverdure N, Erard D, Rohmer B, et al
    Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
    Clin Res Hepatol Gastroenterol. 2023;47:102139.
    PubMed     Abstract available
    
    
    
34. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available
    
    
    
35. YU AT, Khajoueinejad N, Gross A, Golas BJ, et al
    A possible role for ketorolac in the management of increased biliary drain output.
    Clin Res Hepatol Gastroenterol. 2023;47:102128.
    PubMed     Abstract available
    
    
    April 2023
36. SHIAU H, Schraw JM, Mysore K, Cavallo L, et al
    Characteristics of infections and their risk factors in children with biliary atresia.
    Clin Res Hepatol Gastroenterol. 2023;47:102109.
    PubMed     Abstract available
    
    
    
37. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.